Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Neuroleptic malignant syndrome: a case report and discussion (CROSBI ID 243282)

Prilog u časopisu | stručni rad

Grabovac, Vlatko ; Žiga, Sead ; Kereš, Tatjana ; Sorić, Maša Neuroleptic malignant syndrome: a case report and discussion // Signa Vitae, 9 (2014), Suppl. 1; 88-90

Podaci o odgovornosti

Grabovac, Vlatko ; Žiga, Sead ; Kereš, Tatjana ; Sorić, Maša

engleski

Neuroleptic malignant syndrome: a case report and discussion

Neuroleptic malignant syndrome (NMS) is an emergent, life threatening condition most often seen as an iatrogenic complication of neuroleptic or antipsychotic treatment. It is characterized by a tetrad of clinical features: mental status changes, fever, muscle rigidity and autonomic instability, although it is not necessary for all of them to be present at a same time for working diagnosis to be made. This paper will deal with the case of a 29-year old male patient diagnosed with schizophrenia who developed NMS, presented as a generalized tonic-clonic seizure and high fever, after 191 days of in-hospital treatment. After 13 days of hospital treatment in the Intensive Care Unit of Clinical Hospital Dubrava, the patient is in a hemodynamical and proper quantitative mental state and discharged for further psychiatric treatment at his parent hospital institution.

neuroleptic malignant syndrome ; neuroleptics ; creatine kinase

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

9 (Suppl. 1)

2014.

88-90

objavljeno

1334-5605

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost